Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117922 · ClinicalTrials.gov registry record · NA
Philadelphia Preterm Prevention Project
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 1,136
- Enrollment target
NCT01117922: Completed NA study, sponsored by Children's Hospital of Philadelphia.
NCT01117922 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 1,136 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (19% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01117922, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,136 participants
- Enrollment target
Study Summary
This is a randomized clinical trial in which all Philadelphia resident women experiencing a pre-term birth (PTB) at \<34 weeks of gestation (GA) over an 18 month period will be approached at the time of the postpartum hospital stay. Consenting women will be randomized into a usual care group or an interconceptional intervention targeting five risk conditions, all of which increase systemic inflammation. Our primary objective in this study is to assess the efficacy of our interconceptional intervention on the rate of repeat PTB.
Primary Outcome
If women do not become pregnant during the evaluation period of 24 months, they will be seen for study visits every 6 months, and will be seen more often for intervention measures to take place, as needed. For those who become pregnant in the evaluation period, they will be assessed at 20 weeks EGA with their subsequent pregnancy, and asked to sign a release for their subsequent pregnancy records.
Interventions
- OTHER Usual Care Group
- OTHER Psychological intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,136 participants |
| Start Date | 2004-11 |
| Est. Completion | 2008-09 |
| Phase | NA |
What the finished NCT01117922 record still lists
NCT01117922 is an interventional study that assigns participants to a tested intervention. Its 1,136 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (19% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care Group is the first listed.
NCT01117922 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01117922 about?
NCT01117922 is a clinical study titled "Philadelphia Preterm Prevention Project". This is a randomized clinical trial in which all Philadelphia resident women experiencing a pre-term birth (PTB) at \<34 weeks of gestation (GA) over an 18 month period will be approached at the time of the postpartum hospital stay. Consenting women will be randomized into a usual care group or an i...
What is the current status of trial NCT01117922?
This trial is currently completed. It is a NA study. The enrollment target is 1,136 participants. The study started on 2004-11. Estimated completion is 2008-09.
What interventions are being tested in trial NCT01117922?
The interventions under investigation include: Usual Care Group (OTHER), Psychological intervention (OTHER).
Who is sponsoring clinical trial NCT01117922?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01117922's enrollment target sits among peer trials
1,136 93rd of 2000 higher than 1,908 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05894967 · 1,140 participants · NA
Moderators and Mediators of Perceptual Learning
- NCT06532487 · 1,140 participants · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
- NCT06445062 · 1,130 participants · Phase 1
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- NCT06129864 · 1,145 participants · Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia